Evidence map›Paper›PMID 34390768›Full record

ReviewMicrobial pathogenesis2021

Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication.

Sankar Ganesh Ramakrishnan, Becky Robert, Anisha Salim, Padma Ananthan, Muthusaravanan Sivaramakrishnan, Sadhasivam Subramaniam, Sivarajasekar Natesan, Rahul Suresh, G Rajeshkumar, J Prakash Maran and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Microbial pathogenesis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Signal-Amplified Nanobiosensors for Virus Detection Using Advanced Nanomaterials.Advances in biochemical engineering/biotechnology · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Sankar Ganesh RamakrishnanBioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India.
Becky RobertBioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India.
Anisha SalimBioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India.
Padma AnanthanSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
Muthusaravanan SivaramakrishnanUnit Operations laboratory, Department of Biotechnology, Kumaraguru College of Technology, Coimbatore, India.
Sadhasivam SubramaniamBioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India; Department of Extension and Career Guidance, Bharathiar University, Coimbatore, India. Electronic address: sadhaofficial@buc.edu.in.
Sivarajasekar NatesanUnit Operations laboratory, Department of Biotechnology, Kumaraguru College of Technology, Coimbatore, India.
Rahul SureshDepartment of Physics, Bharathiar University, Coimbatore, India.
G RajeshkumarDepartment of Mechanical Engineering, PSG Institute of Technology and Applied Research, Coimbatore, Tamilnadu, India.
J Prakash MaranDepartment of Food Science and Nutrition, Periyar University, Salem, Tamilnadu, India. Electronic address: prakashmaran@gmail.com.
Naif Abdullah Al-DhabiDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Ponmurugan KaruppiahDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia. Electronic address: ponmurugankingsaud@gmail.com.
Mariadhas Valan ArasuDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Bharathiar University · INKing Saud University · SAPeriyar University · INPSG INSTITUTE OF TECHNOLOGY AND APPLIED RESEARCH · INUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zoonotic viruses originate from birds or animal sources and responsible for disease transmission from animals to people through zoonotic spill over and presents a significant global health concern due to lack of rapid diagnostics and therapeutics. The Corona viruses (CoV) were known to be transmitted in mammals. Early this year, SARS-CoV-2, a novel strain of corona virus, was identified as the causative pathogen of an outbreak of viral pneumonia in Wuhan, China. The disease later named corona virus disease 2019 (COVID-19), subsequently spread across the globe rapidly. Nano-particles and viruses are comparable in size, which serves to be a major advantage of using nano-material in clinical strategy to combat viruses. Nanotechnology provides novel solutions against zoonotic viruses by providing cheap and efficient detection methods, novel, and new effective rapid diagnostics and therapeutics. The prospective of nanotechnology in COVID 19 is exceptionally high due to their small size, large surface-to-volume ratio, susceptibility to modification, intrinsic viricidal activity. The nano-based strategies address the COVID 19 by extending their role in i) designing nano-materials for drug/vaccine delivery, ii) developing nano-based diagnostic approaches like nano-sensors iii) novel nano-based personal protection equipment to be used in prevention strategies.This review aims to bring attention to the significant contribution of nanotechnology to mitigate against zoonotic viral pandemics by prevention, faster diagnosis and medication point of view.

Indexed as

COVID-19Pharmaceutical PreparationsAnimalsHumansNanotechnologyProspective StudiesSARS-CoV-2Pharmaceutical Preparationsand diagnosticsCOVID 19NanotechnologySARS-CoV-2TreatmentZoonotic viruses

Identifiers

PMID34390768
PMCPMC8358084
OpenAlexW3195452451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.